Routes & Formulations Flashcards

1
Q

Formulations or Dosage Forms

A

Drugs are contained in dosing units

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Route of Administration

A

A way of getting a drug into or onto the body.

  • Enteral
  • Parenteral
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Enteral

A

Refers to anything involving the stomach from the mouth to the rectum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Parenteral

A

Routes other than enteral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Enteral Formulations

A
  • oral (po)
  • sublingual (sl)
  • buccal
  • rectal (pr)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Parenteral Formulations

A
  • intravenous (IV)
  • intramuscular (IM)
  • ophthalmic
  • intranasal
  • inhalation
  • dermal
  • vaginal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Factors Affecting Selection of Route & Method of Administration

A
  1. Drug characteristics
  2. Ease of administration
  3. Site of action
  4. Onset of action
  5. Duration of action
  6. Quantity of drug administered
  7. Liver or kidney diseases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. Drug Characteristics

pH Scale

A
  • measures the acidity of the alkalinity of a substance
  • pH 7 is neutral (water)
  • stomach is very acidic (pH 1-2)
  • certain drugs are degraded or destroyed by stomach acids
  • absorption of many drugs is affected by the presence of food in the stomach
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. Drug Characteristics

pH Level

A
  • stomach if very acidic (pH 1-2)
  • duodenal pH is higher (closer is neutral)
  • colonic pH is neutral to slightly alkaline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. Drug Characteristics

Drug Research Process

A

The influence of drug characteristics is examined and the formulations approved will have compensated for this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  1. Ease of Administration
A
  • prescribers assess patient characteristics to determine route of administration
  • difficulty in swallowing?
  • consider liquid dose forms or non-oral routes of administration
  • PO route may be inadvisable for patients w/ nausea and vomiting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  1. Site of Action
A
  • route of administration may be influenced by desired site of action
  • local effect
  • systemic effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. Site of Action

Local Effect

A

Site of drug activity and administration are one in the same

e.g. eyes, ears, nose, skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. Site of Action

Systemic Effect

A

The drug is introduced into the circulatory system by any route of administration and carried by the blood to the site of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  1. Onset of Action

Oral Medication

A

Since oral medications for systemic use need to go into solution to exert their effect, solutions or suspensions may work faster than oral tablets or capsules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  1. Onset of Action

Buccal or Sublingual (SL)

A

Medications placed under tongue or between cheek and gums work quickly because they bypass stomach and liver and go directly into bloodstream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
  1. Onset of Action

IV

A

Drugs given IV directly are carried immediately throughout the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
  1. Onset of Action

Localized Therapeutic Effects

A

Those applied to the skin, inhaled into the lungs or instilled into eye

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
  1. Duration of Action
A

Length of time a drug gives the desired effect or is at the therapeutic level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
  1. Duration of Action

Controlled or Extended Release

A

Drug effect lasts longer

e.g. 12 to 24 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q
  1. Duration of Action

Transdermal Patches

A

Delivers small amounts of a drug steadily over many hours or even days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q
  1. Duration of Action

IV

A

Sustained duration effect can be achieved by means of intravenous infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q
  1. Duration of Action

IM and SQ

A

Injections into the muscle and skin last longer than injections directly into the bloodstream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q
  1. Quantity of Drug
A
  • sometimes route of administration is chosen because of the amount of a drug
  • IV infusion is an excellent method for systemic delivery of large quantities of material
  • IV injections and infusions can deliver a higher dose of medication to the target site
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q
  1. Metabolism by the Liver or Excretion by the Kidney

Liver Metabolism

A

Breaks down active drug to inactive metabolites for elimination and prevents drug accumulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q
  1. Metabolism by the Liver or Excretion by the Kidney

First-pass Effect

A
  • is the extent to which a drug is metabolized by the liver before reaching systemic circulation
  • influences activity of some drugs
  • such drugs have to be given in larger oral doses or by different route to bypass metabolism by the liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q
  1. Metabolism by the Liver or Excretion by the Kidney

Effects of Age or Disease-related Change

A
  • age or disease-related changes in liver or kidney function can cause:
  • drug accumulation
  • and potential toxicity
  • drug dosage often needs adjustment in the elderly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q
  1. Metabolism by the Liver or Excretion by the Kidney

Multiple Potent Prescription

A

If patients are on multiple potent prescription drugs, there is a risk of a drug-drug interaction

  • drug accumulation
  • toxic blood levels increases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Oral Dosage Forms

Disintegration

A

The breaking apart of a tablet into smaller pieces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Oral Dosage Forms

Dissolution

A

When the smaller pieces of a disintegrated tablet dissolve in solution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Inactive Ingredients

A
  • include binders, lubricants, fillers, diluents, and disintegrates
  • added to help manufacture the formulation & to help the dosage form disintegrate & dissolve when administered
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Most Frequent Route of Administration

A
  • is PO
  • oral refers to two method
  • applying topically to the mouth for local effect
  • swallowing for absorption through the GI tract into systemic circulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Common Dose Form for Enteral

A

Solid Formation

  • tablets
  • capsule
  • bulk powders
  • rectal formulations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Tablet - Bulk Powders

A

Contain the active drug in a small powder paper or foil envelop. The patient empties the envelop into glass of water or juice and drinks the contents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Tablet - Chewable Tablets

A

Are flavored and are designed to be chewed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Tablet - Effervescent Tablets

A

Are granular salts that release gas and the active ingredient into solution when placed in water or juice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Capsules

A
  • a solid dosage form consisting of a gelatin shell that encloses the drug
  • usually swallowed whole
  • tasteless and are easier to swallow than tablets
  • contains powders, granules, liquids, or some combo w/ one or more active ingredients
  • flavorings are not common for this dose form
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Capsule - Soft or Soft-gel

A

Are capsules that contain liquid instead of powders inside the gelatin shell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Buccal Tablets and Gum

A
  • placed in the buccal pouch
  • between the cheek and the gum
  • dissolved and absorbed by the buccal mucosa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Oral Dose Form

Delayed-release

A
  • does not release the active drug immediately after administration
  • avoid destruction in the stomach
  • reduce GI upset
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Oral Dose Form

Extended-release

A

Allows reduced frequency of dosing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Oral Dose Form

Modified Release Formulation

A
  • delayed-release medication is not the same as extended- or controlled-release medication of the same drug
  • modified-release dose forms should not be split
43
Q

Oral Dose Form

Other Formulation

A
  • long-acting, timed-release, and sustained-release dose forms
  • sustained release (SR)
  • extended release (XR, ER)
  • continuous release (CR)
  • long acting (LA)
44
Q

Liquid Formulation

Solutions

A

A clear liquid

45
Q

Liquid Formulation

Solvent

A

A liquid that can dissolve another substance to form a solution

46
Q

Liquid Formulation

Aqueous Solution

A

Water is the solvent

47
Q

Liquid Formulation

Suspensions

A
  • are formulations in which the drug is not dissolved in the liquid
  • suspensions should be shaken well before dispensing or administration
48
Q

Liquid Formulation

Syrups

A

Are concentrated solutions of sucrose (sugar) in water and are thicker than water

49
Q

Non-aqueous Liquid Formulations

A

Solutions that contain solvent other than water

  • elixirs
  • spirits
  • tinctures
50
Q

Non-aqueous Liquid Formulations

Elixirs

A
  • are sweetened liquids that contain alcohol (5-40%)

- they are less sweet and less effective in masking taste than syrup

51
Q

Non-aqueous Liquid Formulations

Spirits

A

Are alcoholic solutions that contain volatile oils (alcohol 62-85%)

52
Q

Non-aqueous Liquid Formulations

Tinctures

A

Are alcoholic solutions (like spirits) but of nonvolatile substances

53
Q

Liquid Formulation

Emulsions

A

Are solutions of oil and water based substances

  • emulsifier
  • creaming
  • coalescence
54
Q

Liquid Formulation - Emulsions

Emulsifier

A

Is a substance that disperses the oil in to water (w/o emulsion) or water into oil (w/o emulsion)

55
Q

Liquid Formulation - Emulsions

Creaming

A

Occurs when dispersed droplets merge together; can be dispersed by shaking

56
Q

Liquid Formulation - Emulsions

Coalescence

A

Is irreversible separation of the dispersed phase

57
Q

Liquid Formulation

Gels

A
  • made using a substance called gelling agents
  • usually takes 12-24 hours to reach maximum viscosity
  • add the active drug before the gel is formed
58
Q

Unit Dose Disposable Syringes

A

Prefilled syringes that contain a single premeasured dose of medication and are thrown away after use

59
Q

Oral Syringe

A

A device without a needle to administer medication to pediatric or elderly patients unable to swallow tablets or capsules

60
Q

Effervescent Salts

A

Contain one or more medicinal agents and

  • some combination of sodium bicarbonate w/ citric acid, tartaric acid, or sodium biphosphate
  • release carbon dioxide gas when dissolved
61
Q

Lozenges

A

Contain active ingredients and flavorings that are dissolved in the mouth

  • also known as troches or pastilles
  • generally have local effects
62
Q

Dropper

A
  • contains a small, squeezable bulb at one end and a hollow glass or plastic tube with a tapering point
  • frequently incorporated into the cap of a vial or other container
  • often used for otic or ophthalmic administration
63
Q

gtt

A

Abbreviation for drops

64
Q

Sublingual Administration

A
  • designed to dissolve under the tongue and very quickly
  • nitroglycerin (NTG) is the best known example of SL formulation
  • advise patients to take a sip of water first and not to eat food or beverages until the drug is fully absorbed
65
Q

Oral Dose Form

A
  • capsules are preferred over tablets for patients with difficulty swallowing
  • water preferred over beverages to aid in swallowing
  • some dose forms are designed to be sprinkled on food when swallowing a solid is difficult
  • liquid doses are swallowed more easily and are suitable for
  • patients with swallowing difficulties
  • small children
66
Q

Advantages of Oral Route

A
  • ease and safety of administration
  • active ingredient is generally contained in powders or granules which dissolve in GI tract
  • sublingual (and buccal) administration has a rapid onset (less than 5 minutes)
67
Q

Disadvantages of Oral Route

A
  • delayed onset, dose form must disintegrate before absorption
  • destruction or dilution of drug by GI fluids and acid or food or drink in stomach or intestines
  • not indicated in patients who have N&V or are comatose, sedated, or unable to swallow
  • unpleasant taste of some liquid dose forms, must be masked by flavorings to promote compliance
  • some drugs given SL or buccally have a short duration of action
  • buccal route may have medicinal taste or local mouth irritation
68
Q

Dispensing Oral Medications - NTG

A
  • patients need instruction on proper storage of NTG
  • SL NTG tablets should be stored in their original container (brown glass bottle)
  • lid screwed on tightly to prevent loss of potency
  • pillboxes should be discouraged
  • refill NTG with a fresh bottle every 6 months
69
Q

Rectal Medication - Suppository

A
  • remove suppository from its package
  • insert tapered end first w/ index finger for the full length of the finger
  • may need to be lubricated w/ a water soluble gel to ease insertion
  • refrigeration may make insertion of rectal medications easier in warm climates
70
Q

Rectal Formulations

A

Is preferred when

  • oral drug might be destroyed by acidic fluids in the stomach
  • oral drug might be too readily metabolized by the liver and eliminated from the body
  • patient is unconscious and needs medication
  • N&V or severe acute illness in the GI tract make patient unable to take oral drugs
  • the site of action is local to the rectum
71
Q

Parenteral Routes of Administration

A
  • an injection or infusion by means of a needle or catheter inserted into the body
  • parenteral forms deserve special attention, complexity, potential for therapeutic benefit and danger including risk of infection
  • this route of administration bypasses the GI tract
72
Q

Parenteral Routes of Administration

Injection Independent

A
  • ophthalmic
  • intranasal
  • inhalation
  • dermal
  • vaginal
  • otic
73
Q

Parenteral Routes of Administration

Injection Dependent

A
  • intravenous
  • intramuscular
  • intradermal
  • subcutaneous
  • epidural
  • intrathecal
74
Q

Parenteral Forms for Injection

A
  • parenteral preparations must be sterile
  • parenterals are prepared using
  • aseptic techniques
  • special clothing (gowns, masks, hair net, gloves)
  • laminar flow hoods placed in special rooms
75
Q

Parenteral Dosage Forms

A
  • IV route directly into a vein
  • prepared in hospitals and home healthcare pharmacies
  • antibiotics
  • chemotherapy
  • analgesics
  • nutrition
  • critical care medications
76
Q

Needle Size Recommendation

A
  • Intravenous 16-20 gauge, 1-1.5” length
  • Intramuscular 19-22 gauge, 1-1.5” length
  • Subcutaneous 24-27 gauge, 3/8-1” length
  • Intradermal 25-26 gauge, 3/8” length
77
Q

Parenteral Route

A
  • disposable syringes and needles are used to administer drugs by injection
  • different sizes are available depending on the type of medication and injection needed
  • IV infusion can provide a continuous amount of needed medication without fluctuation in blood levels of other routes
  • infusion rate can be adjusted, provides more or less medication as the situation dictates
78
Q

Intravenous Formulation

A
  • administered directly into a vein
  • takes about 20 seconds to circulate throughout the body
  • aqueous solutions are the most common formulation
  • syringeability
  • injectibility
79
Q

Syringeability

A

The ease with which a material can be drawn from container into a syringe

80
Q

Injectibility

A

The ease of flow when a material is injected into patient

81
Q

Intravenous Injections or Infusions

A

Intravenous injections are injected directly into veins and are administered at a 15-20 degree angle

82
Q

Intravenous Administration Devices

Infusion

A
  • gradual IV injection of a volume, usually 500-1000ml, of fluid into a patient
  • e.g. dextrose in water 5% (D5W), 0.9% sodium chloride in water (NS)
  • solution bag has two ports: an administration set port and a medication port
83
Q

Intravenous Administration Devices

Infusion Pump

A
  • ensures consistent and controlled delivery rate

- patient controlled analgesia (PCA) are pumps for self administration or pain medication

84
Q

Parenteral Route Advantages

A
  • IV route is the fastest method for delivering systemic drugs, preferred route in an emergency situation
  • can provide fluids, electrolytes, and nutrition; patients who cannot take food or have serious problems w/ GI tract
  • provides higher concentration of drug to bloodstream or tissues; advantageous in serious bacterial infection
85
Q

Parenteral Route Disadvantages

A
  • formulation is limited to solutions, suspensions, and emulsions
  • has to be sterile (bacteria free)
  • pH must match body fluid’s using buffer system
  • limited volume should be used to avoid pain and necrosis
  • higher cost, drug and auxiliary devices
  • required skilled personnel to administer them
  • most difficult to remove once administered if there is an adverse or toxic reaction
  • requires a needle for injection
  • potential for additional adverse events, e.g. infection or clots
86
Q

IV Formulation Complications

A
  • thrombus formation
  • phlebitis
  • air emboli
  • particulate material can include small pieces of glass that chip from the product’s vial or rubber pieces from the stopper
87
Q

Intramuscular Injections

A
  • care must be taken with deep IM injections to avoid hitting a vein, artery, or nerve
  • in adults, IM injections are given into upper, outer portion of the gluteus maximus
  • for children and some adults, IM injections are given into the deltoid muscles of the shoulders
  • depot - the area in the muscle where the formulation is injected
88
Q

Intramuscular Injections Needle

A
  • typical needle is 22 to 25 gauge, 1/2 to 1 in needle
  • IM injections are administered at a 90 degree angle
  • volume limited to less than 3 ml
89
Q

Advantages and Disadvantages of the IM Route

A
  • IM and subcutaneous routes of administration are convenient ways to deliver medications compared with IV route
  • onset of response of medication may be slower
  • duration of action can be longer
  • practical for use outside hospital
  • used for drugs which are not active orally
  • injection site needs to be “prepped” using alcohol wipe
  • correct syringe, needle, and technique must be used
  • rotation of injection site with long-term use to prevent scarring and other skin changes and can influence drug absorption
90
Q

Subcutaneous Injection

A
  • administer medications below the skin into the subcutaneous fat
  • outside of the upper arm
  • top of the thigh
  • lower portion of each side of the abdomen
  • not into grossly adipose, hardened, inflamed or swollen tissue
  • often have a longer onset of action and a longer duration of action when compared w/ IM or IV
91
Q

Subcutaneous Injection Needle

A
  • given at a 45 degree angle
  • 25-26 gauge needle, 3/8 to 5/8 in length
  • no more than 1.5 ml should be injected into the site; avoids pressure on sensory nerves causing pain and discomfort
92
Q

Subcutaneous Injection Insulin

A
  • given using 30-32 gauge short needles, special syringe that measures in units
  • keep insulin refrigerated
  • check expiration dates frequently, open vials should be discarded after 28 days
  • vial of insulin is mixed by rolling between the hands and never shaken
  • rubber stopper should be wiped w/ an alcohol wipe
93
Q

Intradermal Injection

A
  • given into capillary-rich layer just below epidermis for
  • local anesthesia
  • diagnostic tests
  • immunizations
94
Q

Examples of Intradermal Injections

A
  • skin test for TB, typical site is upper forearm, below area where IV injections are given
  • allergy skin testing
  • small amounts of various allergens are administered to detect allergies
  • usually on the back
95
Q

Implants (or Pellets)

A
  • are dosage forms placed under the skin by means of minor surgery
  • used for long-term, controlled release of medications
  • enhanced patient compliance and convenience
  • complications at the site of insertion have limited use
  • e.g. viadur, duros, supperlin LA
96
Q

Plasters

A

Are solid or semisolid preparations that adhere to the body

97
Q

Topical Routes of Administration

A
  • the application of a drug directly to the surface of the skin
  • includes administration of drugs to any mucous membrane:
  • nose
  • ears
  • vagina
  • urethra
  • colon
  • lungs
98
Q

Ophthalmic Medication

A
  • administered for local treatment
  • must be at room temperature or body temperature before application
  • have to be sterile; only preparations w/ preservatives can be repeatedly used
  • major problem is the immediate loss of dose by natural spillage from eye and about 80% of a dose will be lost from the eye overflow
  • unused ophthalmic mediations should be discarded 30 days after container is opened
  • manufacturer expirations do not apply once opened
99
Q

Ophthalmic Ointments Formulation

A
  • tend to keep the drug in contact with the eye longer than solutions
  • most ointments are made of mineral oil and white petroleum and have a melting point close to body temperature
  • ointment cause blurring of vision and should be applied at night
100
Q

Ophthalmic Administration (Preparation)

A
  • before application, patient should wash hands, prevents contamination of application site
  • tube or dropper should not touch the application site, medication may become contaminated
  • only sterile ophthalmic solutions or suspensions should be used in the eye
  • ear drops can never be used in the eye, eye drops can be used in the ear
101
Q

Ophthalmic Administration

A
  • patient’s head should be tilted back
  • after administration, patient should place a finger in the corner of the eye, next to the nose to close the lacrimal gently, prevents loss of medication through tear duct
  • patient should also keep the eyes closed for 1-2 minutes after application
  • when multiple drops of more than one medication are administered, the patient should wait 5 minutes between different medication
  • if an ointment and a drop are used together, the drop is used first, wait 10 minutes before applying the ointment
102
Q

Contact Lenses

A

-if patient is allowed to wear contact lenses, the lens should be put in the eye 5 minutes after the solution is used

103
Q

Ocular Inserts

A
  • Ocusert is an ocular insert designed to deliever pilocarpine at a controlled rate for up to 7 days
  • lenses placed in a solution containing a drug and the lenses absorb the drub solution